EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
NOTICE OF BOARD MEETING
Monthly Return of Equity Issuer on Movements in Securities
INSIDE INFORMATION - UPDATES ON 2024 PRELIMINARY ANNUAL RESULTS
VOLUNTARY ANNOUNCEMENT - DTCP-HIB-MCV4 COMBINED VACCINE OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
VOLUNTARY ANNOUNCEMENT - THE CENTER FOR DRUG EVALUATION, NMPA GRANTED PRIORITY REVIEW STATUS TO NDA FOR DTCP INFANT
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR TETANUS VACCINE
Monthly Return of Equity Issuer on Movements in Securities
INSIDE INFORMATION - RESULTS FORECAST FOR THE YEAR 2024
Monthly Return of Equity Issuer on Movements in Securities
VOLUNTARY ANNOUNCEMENT - MENHYCIA OBTAINS DRUG REGISTRATION CERTIFICATE IN INDONESIA
1
2
3
4
5
6
45
津公网安备12011602300399
